Type 1 diabetes in pre-school children--long-term metabolic control, associated autoimmunity and complications

Y Levy-Shraga1, L Lerner-Geva, V Boyko

  • 1Pediatric Endocrine and Diabetes Unit, Safra Children's Hospital, Sheba Medical Center, Raanana, Israel. yael.levy.shraga@gmail.com

Insights

Children with early-onset Type 1 diabetes (T1D) face a higher risk of celiac disease. While metabolic control is achievable until age 10, it declines afterward, with higher HbA1c linked to longer T1D duration.

Area of Science:

  • Pediatric Endocrinology
  • Autoimmune Diseases
  • Metabolic Disorders

Background:

  • Type 1 diabetes (T1D) diagnosis in early childhood presents unique clinical challenges.
  • Understanding the long-term implications of early-onset T1D is crucial for effective management.
  • Co-morbidity rates and metabolic control in very young T1D patients require further investigation.

Purpose of the Study:

  • To identify clinical characteristics and co-morbidity rates in children diagnosed with Type 1 diabetes mellitus before the age of 6 years.
  • To compare these findings with a cohort of children diagnosed with T1D at an older age.

Main Methods:

  • Retrospective chart review of 103 patients diagnosed with T1D before age 6 (study group) and 220 patients diagnosed after age 6 (comparison group).
  • Comparison of glycaemic control (HbA1c) and occurrence of co-morbidities including celiac disease, autoimmune thyroid disease, hypertension, nephropathy, and retinopathy.
  • Statistical analysis using P-values and Kaplan-Meier survival analysis for diagnosis rates.

Main Results:

  • Children diagnosed with T1D before age 6 had a significantly higher rate of celiac disease diagnosis within 10 years (14.4% vs 4.2%, P log-rank = 0.03).
  • Higher mean HbA1c levels were observed in the early-onset group until age 10, with subsequent deterioration (8.0-8.2% rising to 8.8%).
  • The early-onset group experienced more severe hypoglycaemic events (P = 0.03), but adjusted HbA1c differences were not significant after accounting for diabetes duration.

Conclusions:

  • Early-onset T1D (before age 6) is associated with an increased risk of developing celiac disease.
  • Good metabolic control in early-onset T1D is achievable up to age 10, but tends to worsen thereafter.
  • Elevated HbA1c levels in this cohort are linked to the duration of the disease, not necessarily earlier diagnosis alone.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...